Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
Annals of Hematology|December 6, 2006
Extended follow-up of outcome measures in multiple myeloma patients treated on a phase I study with bortezomib and pegylated liposomal doxorubicinSuzanne E Biehn, Dominic T Moore, Peter M Voorhees, et al.
Molecular Cell|May 8, 2021
WNK1 is an assembly factor for the human ER membrane protein complexTino Pleiner, Masami Hazu, Giovani Pinton Tomaleri, et al.
Leukemia Research|June 24, 2019
Efficacy and safety results from a phase 1b/2, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myelomaParameswaran Hari, Claudia E Paba-Prada, Peter M Voorhees, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 5, 2025
Plasma Proteomic Profiles Among White and African American Individuals With Monoclonal Gammopathy of Unknown Significance (MGUS) and Multiple Myeloma (MM)Cindy Varga, Kip D Zimmerman, David M Foureau, et al.
Molecular Cell|March 1, 2024
Triaging of α-helical proteins to the mitochondrial outer membrane by distinct chaperone machinery based on substrate topologyGayathri Muthukumar, Taylor A Stevens, Alison J Inglis, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2023
Triaging of α-helical proteins to the mitochondrial outer membrane by distinct chaperone machinery based on substrate topologyGayathri Muthukumar, Taylor A Stevens, Alison J Inglis, et al.
Life (Basel, Switzerland)|March 28, 2024
Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study)Hamid Ehsan, Myra Robinson, Peter M Voorhees, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Role of a holo-insertase complex in the biogenesis of biophysically diverse ER membrane proteinsKatharine R Page, Vy N Nguyen, Tino Pleiner, et al.
Oncotarget|September 2, 2015
A phase 2, open-label, multicenter study of the long-term safety of siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman diseaseFrits van Rhee, Corey Casper, Peter M Voorhees, et al.
British Journal of Haematology|January 6, 2021
Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: long-term survival follow-up from the Phase II study O-12-M1Sara Bringhen, Peter M Voorhees, Torben Plesner, et al.
Pageof 15